Sponsor Pipeline

Imperial College London Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
159
Active Trials
89
Recruiting
3
Phase 3
10
Disease Areas
20
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT05492110
Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed…
Enrollment closed, study ongoing
2026-08-13 NCT05492110
Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed…
date change Primary completion pushed: 2026-03-06 -> 2026-08-04
2026-08-13 NCT05492110
Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed…
date change Completion pushed: 2026-03-06 -> 2026-08-05
2026-08-09 NCT06383130
London Asthma Diagnostics Study
overall status: Not Yet Recruiting → Unknown
2026-08-09 NCT05635344
A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar…
overall status: Recruiting → Unknown
2026-08-02 NCT06504641
I4F: Isla for Frailty Feasibility Study
overall status: Recruiting → Unknown
2026-08-02 NCT05987670
Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled…
overall status: Active, Not Recruiting → Unknown
2026-08-02 NCT05431296
Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes
overall status: Recruiting → Unknown
2026-08-02 NCT03416413
Study of Foam Sclerotherapy Versus Ambulatory Phlebectomy
overall status: Recruiting → Unknown
2026-07-30 NCT06611293
HOspital Versus Primary Care Breath Test Environment (HOPE) Study
Trial completed
2026-07-30 NCT06611293
HOspital Versus Primary Care Breath Test Environment (HOPE) Study
Enrollment reduced: 80 -> 59 participants
2026-07-30 NCT06611293
HOspital Versus Primary Care Breath Test Environment (HOPE) Study
date change Primary completion moved earlier: 2026-04 -> 2025-12-20
2026-07-30 NCT06611293
HOspital Versus Primary Care Breath Test Environment (HOPE) Study
date change Completion moved earlier: 2026-10 -> 2025-12-20
2026-07-24 NCT03835273
Oesophagectomy and Chest Wall and Respiratory Function
critical Trial terminated
2026-07-24 NCT03835273
Oesophagectomy and Chest Wall and Respiratory Function
Enrollment reduced: 100 -> 73 participants
2026-07-24 NCT03835273
Oesophagectomy and Chest Wall and Respiratory Function
date change Primary completion moved earlier: 2025-08-31 -> 2024-08-31
2026-07-24 NCT03835273
Oesophagectomy and Chest Wall and Respiratory Function
date change Completion moved earlier: 2025-08-31 -> 2024-08-31
2026-07-19 NCT07397455
Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron…
Recruitment opened
2026-07-19 NCT07397455
Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron…
Primary endpoint(s) modified
2026-07-19 NCT07397455
Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron…
Trial sites expanded: 0 -> 5 locations
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-07 NCT07752654 TransThoracic Ultrasound for Descending Aortic Aneurysms Not Yet Recruiting
2026-07-30 NCT07737522 Myocardial Metabolic Flux in Pulmonary Arterial Hypertension Phase 2 Not Yet Recruiting
2026-07-20 NCT07713628 Immune Reponses to RSV B Challenge in Older Adults (A Controlled Human Infection Study… Not Yet Recruiting
2026-07-20 NCT07714538 Breath Research Narrow Validation for Gastrointestinal Cancer Detection Not Yet Recruiting
Active Trials by Phase
Phase 4
1
Phase 3
3
Phase 2
15
Phase 1/2
1
Phase 1
4
Early Phase 1
1
Not specified
134
Active Trials — top 25 of 159
NCT IDTitleConditionStatus
Phase 4
NCT05735639 THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) Venous Thromboembolism Recruiting
Phase 3
NCT05085028 A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy… Lung Cancer, Nonsmall Cell Recruiting
NCT05395195 Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial) Encephalopathy Recruiting
NCT05889507 Cooling in Mild Encephalopathy Neonatal Encephalopathy Recruiting
Phase 2
NCT04319367 A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly… HIV/AIDS and Infections Recruiting
NCT06355583 Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial Acute Lymphoblastic Leukaemia Recruiting
NCT07682233 Role of a Mitochondrial Receptor in Blood Sugar Regulation Heathly Volunteers Recruiting
NCT05318794 Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer Gastric Cancer Not Yet Recruiting
NCT03763253 Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of… Prostate Cancer Active, Not Recruiting
NCT07172815 PDE5 Inhibitor for Alzheimer's Disease Alzheimer Disease Not Yet Recruiting
NCT07191821 TSPO Modulation in AD Alzheimer s Disease Enrolling by Invitation
NCT07200622 Oral Semaglutide in Patients With Alzheimer's Disease Alzheimer Disease Not Yet Recruiting
NCT07295834 Modafinil For Fatigue in IBD: A Feasibility Randomised Controlled Trial Crohn Disease (CD) Not Yet Recruiting
NCT06232564 A Study of Etoposide-carboplatin in Combination With Pembrolizumab and Lenvatinib… Neuroendocrine Tumors Active, Not Recruiting
NCT07389031 Maralixibat for Intrahepatic Cholestasis of Pregnancy Intrahepatic Cholestasis of Pregnancy Not Yet Recruiting
NCT07112352 Healthy Ageing: a Feasibility Study to Evaluate Digitally-enabled Ways to Support Healthy… Frailty Active, Not Recruiting
NCT06230354 Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic… EGPA - Eosinophilic Granulomatosis With Polyangiitis Active, Not Recruiting
NCT05109169 METformin and FINGER Intervention to Prevent Cognitive Impairment and Disability in Older… Cognitive Decline Active, Not Recruiting
NCT07737522 Myocardial Metabolic Flux in Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension Not Yet Recruiting
Phase 1/2
NCT03991780 Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection Renal Transplant Rejection Active, Not Recruiting
Phase 1
NCT05178693 Lutathera and ASTX727 in Neuroendocrine Tumours Neuroendocrine Tumors Recruiting
NCT07397455 Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron… SARS-CoV-2 (COVID-19) Recruiting
NCT05646082 Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination… Refractory HIV Associated Kaposi Sarcoma Active, Not Recruiting
NCT07697183 TSPO Endothelial - EMPATHY PAH Enrolling by Invitation
Early Phase 1
NCT06798636 PsiloIMAGINE: A Psychedelic-augmented Mental Imagery-based Intervention for Young People… Self Harm Recruiting
See all 159 active Imperial College London trials with filters →
Disease Areas
Get alerts when Imperial College London's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free